The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pharyngitis Drug Market Research Report 2025
Synopsis
Pharyngitis is a clinical disorder that involves inflammation in the pharynx i.e. the back of the throat. A painful throat is referred to as pharyngitis. Itching and trouble swallowing are other symptoms of pharyngitis. Pharyngitis is caused by a variety of bacterial and viral agents, the most common of which are measles, adenovirus, high cough, and streptococcus. A viral infection, e.g. the common cold, influenza, or mononucleosis, is the most prevalent cause of pharyngitis.
Global Pharyngitis Drug market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Pharyngitis Drug market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Pharyngitis Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Genentech Inc
Adamas Pharmaceutical Inc
PLIVA HRVATSKA d.o.o
Pfizer Inc
Valeant Pharmaceuticals International, Inc
Mylan N.V
GSK group of companies
Teva Pharmaceutical Industries Ltd
AbbVie Inc
Viatris Inc. (Mylan)
GlaxoSmithKline plc
Abbott Laboratories
Amgen Inc
Sanofi-aventis Groupe
Purdue Pharma L.P
Segment by Type
Tablet
Capsule
Spray
Solution
Other
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Pharyngitis Drug report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Pharyngitis is a clinical disorder that involves inflammation in the pharynx i.e. the back of the throat. A painful throat is referred to as pharyngitis. Itching and trouble swallowing are other symptoms of pharyngitis. Pharyngitis is caused by a variety of bacterial and viral agents, the most common of which are measles, adenovirus, high cough, and streptococcus. A viral infection, e.g. the common cold, influenza, or mononucleosis, is the most prevalent cause of pharyngitis.
Global Pharyngitis Drug market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Pharyngitis Drug market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Pharyngitis Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Genentech Inc
Adamas Pharmaceutical Inc
PLIVA HRVATSKA d.o.o
Pfizer Inc
Valeant Pharmaceuticals International, Inc
Mylan N.V
GSK group of companies
Teva Pharmaceutical Industries Ltd
AbbVie Inc
Viatris Inc. (Mylan)
GlaxoSmithKline plc
Abbott Laboratories
Amgen Inc
Sanofi-aventis Groupe
Purdue Pharma L.P
Segment by Type
Tablet
Capsule
Spray
Solution
Other
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Pharyngitis Drug report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Pharyngitis Drug Market Overview
1.1 Product Overview and Scope of Pharyngitis Drug
1.2 Pharyngitis Drug Segment by Type
1.2.1 Global Pharyngitis Drug Market Value Comparison by Type (2023-2029)
1.2.2 Tablet
1.2.3 Capsule
1.2.4 Spray
1.2.5 Solution
1.2.6 Other
1.3 Pharyngitis Drug Segment by Application
1.3.1 Global Pharyngitis Drug Market Value by Application: (2023-2029)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Pharyngitis Drug Market Size Estimates and Forecasts
1.4.1 Global Pharyngitis Drug Revenue 2018-2029
1.4.2 Global Pharyngitis Drug Sales 2018-2029
1.4.3 Global Pharyngitis Drug Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Pharyngitis Drug Market Competition by Manufacturers
2.1 Global Pharyngitis Drug Sales Market Share by Manufacturers (2018-2023)
2.2 Global Pharyngitis Drug Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Pharyngitis Drug Average Price by Manufacturers (2018-2023)
2.4 Global Pharyngitis Drug Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Pharyngitis Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pharyngitis Drug, Product Type & Application
2.7 Pharyngitis Drug Market Competitive Situation and Trends
2.7.1 Pharyngitis Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pharyngitis Drug Players Market Share by Revenue
2.7.3 Global Pharyngitis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pharyngitis Drug Retrospective Market Scenario by Region
3.1 Global Pharyngitis Drug Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Pharyngitis Drug Global Pharyngitis Drug Sales by Region: 2018-2029
3.2.1 Global Pharyngitis Drug Sales by Region: 2018-2023
3.2.2 Global Pharyngitis Drug Sales by Region: 2024-2029
3.3 Global Pharyngitis Drug Global Pharyngitis Drug Revenue by Region: 2018-2029
3.3.1 Global Pharyngitis Drug Revenue by Region: 2018-2023
3.3.2 Global Pharyngitis Drug Revenue by Region: 2024-2029
3.4 North America Pharyngitis Drug Market Facts & Figures by Country
3.4.1 North America Pharyngitis Drug Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Pharyngitis Drug Sales by Country (2018-2029)
3.4.3 North America Pharyngitis Drug Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pharyngitis Drug Market Facts & Figures by Country
3.5.1 Europe Pharyngitis Drug Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Pharyngitis Drug Sales by Country (2018-2029)
3.5.3 Europe Pharyngitis Drug Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pharyngitis Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Pharyngitis Drug Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Pharyngitis Drug Sales by Country (2018-2029)
3.6.3 Asia Pacific Pharyngitis Drug Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Pharyngitis Drug Market Facts & Figures by Country
3.7.1 Latin America Pharyngitis Drug Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Pharyngitis Drug Sales by Country (2018-2029)
3.7.3 Latin America Pharyngitis Drug Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pharyngitis Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Pharyngitis Drug Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Pharyngitis Drug Sales by Country (2018-2029)
3.8.3 Middle East and Africa Pharyngitis Drug Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pharyngitis Drug Sales by Type (2018-2029)
4.1.1 Global Pharyngitis Drug Sales by Type (2018-2023)
4.1.2 Global Pharyngitis Drug Sales by Type (2024-2029)
4.1.3 Global Pharyngitis Drug Sales Market Share by Type (2018-2029)
4.2 Global Pharyngitis Drug Revenue by Type (2018-2029)
4.2.1 Global Pharyngitis Drug Revenue by Type (2018-2023)
4.2.2 Global Pharyngitis Drug Revenue by Type (2024-2029)
4.2.3 Global Pharyngitis Drug Revenue Market Share by Type (2018-2029)
4.3 Global Pharyngitis Drug Price by Type (2018-2029)
5 Segment by Application
5.1 Global Pharyngitis Drug Sales by Application (2018-2029)
5.1.1 Global Pharyngitis Drug Sales by Application (2018-2023)
5.1.2 Global Pharyngitis Drug Sales by Application (2024-2029)
5.1.3 Global Pharyngitis Drug Sales Market Share by Application (2018-2029)
5.2 Global Pharyngitis Drug Revenue by Application (2018-2029)
5.2.1 Global Pharyngitis Drug Revenue by Application (2018-2023)
5.2.2 Global Pharyngitis Drug Revenue by Application (2024-2029)
5.2.3 Global Pharyngitis Drug Revenue Market Share by Application (2018-2029)
5.3 Global Pharyngitis Drug Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Genentech Inc
6.1.1 Genentech Inc Corporation Information
6.1.2 Genentech Inc Description and Business Overview
6.1.3 Genentech Inc Pharyngitis Drug Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Genentech Inc Pharyngitis Drug Product Portfolio
6.1.5 Genentech Inc Recent Developments/Updates
6.2 Adamas Pharmaceutical Inc
6.2.1 Adamas Pharmaceutical Inc Corporation Information
6.2.2 Adamas Pharmaceutical Inc Description and Business Overview
6.2.3 Adamas Pharmaceutical Inc Pharyngitis Drug Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Adamas Pharmaceutical Inc Pharyngitis Drug Product Portfolio
6.2.5 Adamas Pharmaceutical Inc Recent Developments/Updates
6.3 PLIVA HRVATSKA d.o.o
6.3.1 PLIVA HRVATSKA d.o.o Corporation Information
6.3.2 PLIVA HRVATSKA d.o.o Description and Business Overview
6.3.3 PLIVA HRVATSKA d.o.o Pharyngitis Drug Sales, Revenue and Gross Margin (2018-2023)
6.3.4 PLIVA HRVATSKA d.o.o Pharyngitis Drug Product Portfolio
6.3.5 PLIVA HRVATSKA d.o.o Recent Developments/Updates
6.4 Pfizer Inc
6.4.1 Pfizer Inc Corporation Information
6.4.2 Pfizer Inc Description and Business Overview
6.4.3 Pfizer Inc Pharyngitis Drug Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Pfizer Inc Pharyngitis Drug Product Portfolio
6.4.5 Pfizer Inc Recent Developments/Updates
6.5 Valeant Pharmaceuticals International, Inc
6.5.1 Valeant Pharmaceuticals International, Inc Corporation Information
6.5.2 Valeant Pharmaceuticals International, Inc Description and Business Overview
6.5.3 Valeant Pharmaceuticals International, Inc Pharyngitis Drug Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Valeant Pharmaceuticals International, Inc Pharyngitis Drug Product Portfolio
6.5.5 Valeant Pharmaceuticals International, Inc Recent Developments/Updates
6.6 Mylan N.V
6.6.1 Mylan N.V Corporation Information
6.6.2 Mylan N.V Description and Business Overview
6.6.3 Mylan N.V Pharyngitis Drug Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Mylan N.V Pharyngitis Drug Product Portfolio
6.6.5 Mylan N.V Recent Developments/Updates
6.7 GSK group of companies
6.6.1 GSK group of companies Corporation Information
6.6.2 GSK group of companies Description and Business Overview
6.6.3 GSK group of companies Pharyngitis Drug Sales, Revenue and Gross Margin (2018-2023)
6.4.4 GSK group of companies Pharyngitis Drug Product Portfolio
6.7.5 GSK group of companies Recent Developments/Updates
6.8 Teva Pharmaceutical Industries Ltd
6.8.1 Teva Pharmaceutical Industries Ltd Corporation Information
6.8.2 Teva Pharmaceutical Industries Ltd Description and Business Overview
6.8.3 Teva Pharmaceutical Industries Ltd Pharyngitis Drug Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Teva Pharmaceutical Industries Ltd Pharyngitis Drug Product Portfolio
6.8.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
6.9 AbbVie Inc
6.9.1 AbbVie Inc Corporation Information
6.9.2 AbbVie Inc Description and Business Overview
6.9.3 AbbVie Inc Pharyngitis Drug Sales, Revenue and Gross Margin (2018-2023)
6.9.4 AbbVie Inc Pharyngitis Drug Product Portfolio
6.9.5 AbbVie Inc Recent Developments/Updates
6.10 Viatris Inc. (Mylan)
6.10.1 Viatris Inc. (Mylan) Corporation Information
6.10.2 Viatris Inc. (Mylan) Description and Business Overview
6.10.3 Viatris Inc. (Mylan) Pharyngitis Drug Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Viatris Inc. (Mylan) Pharyngitis Drug Product Portfolio
6.10.5 Viatris Inc. (Mylan) Recent Developments/Updates
6.11 GlaxoSmithKline plc
6.11.1 GlaxoSmithKline plc Corporation Information
6.11.2 GlaxoSmithKline plc Pharyngitis Drug Description and Business Overview
6.11.3 GlaxoSmithKline plc Pharyngitis Drug Sales, Revenue and Gross Margin (2018-2023)
6.11.4 GlaxoSmithKline plc Pharyngitis Drug Product Portfolio
6.11.5 GlaxoSmithKline plc Recent Developments/Updates
6.12 Abbott Laboratories
6.12.1 Abbott Laboratories Corporation Information
6.12.2 Abbott Laboratories Pharyngitis Drug Description and Business Overview
6.12.3 Abbott Laboratories Pharyngitis Drug Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Abbott Laboratories Pharyngitis Drug Product Portfolio
6.12.5 Abbott Laboratories Recent Developments/Updates
6.13 Amgen Inc
6.13.1 Amgen Inc Corporation Information
6.13.2 Amgen Inc Pharyngitis Drug Description and Business Overview
6.13.3 Amgen Inc Pharyngitis Drug Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Amgen Inc Pharyngitis Drug Product Portfolio
6.13.5 Amgen Inc Recent Developments/Updates
6.14 Sanofi-aventis Groupe
6.14.1 Sanofi-aventis Groupe Corporation Information
6.14.2 Sanofi-aventis Groupe Pharyngitis Drug Description and Business Overview
6.14.3 Sanofi-aventis Groupe Pharyngitis Drug Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Sanofi-aventis Groupe Pharyngitis Drug Product Portfolio
6.14.5 Sanofi-aventis Groupe Recent Developments/Updates
6.15 Purdue Pharma L.P
6.15.1 Purdue Pharma L.P Corporation Information
6.15.2 Purdue Pharma L.P Pharyngitis Drug Description and Business Overview
6.15.3 Purdue Pharma L.P Pharyngitis Drug Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Purdue Pharma L.P Pharyngitis Drug Product Portfolio
6.15.5 Purdue Pharma L.P Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pharyngitis Drug Industry Chain Analysis
7.2 Pharyngitis Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pharyngitis Drug Production Mode & Process
7.4 Pharyngitis Drug Sales and Marketing
7.4.1 Pharyngitis Drug Sales Channels
7.4.2 Pharyngitis Drug Distributors
7.5 Pharyngitis Drug Customers
8 Pharyngitis Drug Market Dynamics
8.1 Pharyngitis Drug Industry Trends
8.2 Pharyngitis Drug Market Drivers
8.3 Pharyngitis Drug Market Challenges
8.4 Pharyngitis Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
